Table 4 Binary and multivariable Logistic analysis of factors associated with malnutrition among epileptic patients at GUSCH pediatric neurology follow-up clinic, 2021(n = 239)

Age

<=5 years

34

21

1.51 (0.62–3.70)

0.40(0.07–2.30)

0.31

5–10 years

56

29

1.81 (0.79–4.17)

0.77(0.185–3.16)

0.71

10-15years

35

33

0.99(0.43–2.33)

0.73(0.25–2.12)

0.57

15-18years

15

15

1

.

Sex

Male

55

96

0.51(0.02–1.04)

1.96(1.05–3.69)

0.04

Female

43

45

1

.

Paternal education

No formal education

69

36

1.65(0.97–2.79)

1.88(1.01–3.50)

0.05

Primary and above

72

62

1

.

Motor developmental delay

No

102

88

3.36(1.59–7.13)

1

.

Yes

39

10

5.91(1.55–22.49)

0.01

Language developmental delay

No

97

77

1.66(0.91–3.03)

1

.

Yes

44

21

0.40(0.11–1.38)

0.15

Cognitive developmental delay

No

97

78

1.77(0.96–9.25)

1

.

Yes

44

20

0.85(0.22–3.24)

0.81

Age at diagnosis

<=1 years

33

15

0.58(0.28–1.20)

1

.

1–5 years

52

41

0.86(0.38–1.95)

0.55(0.21–1.43)

0.22

5–10 years

38

20

0.37(0.16–0.89)

0.79(0.23–2.75)

0.71

>=10 years

18

22

0.28(0.05–1.49)

0.14

Duration after diagnosis of epilepsy

<=1 years

33

15

0.58(0.28–1.20)

1

.

1–5 years

52

41

0.86(0.38–1.95)

0.71(0.33–1.55)

0.39

5–10 years

38

20

0.37(0.16–0.89)

0.58(0.17-2.00)

0.39

>=10 years

18

22

0.29(0.04–2.02)

0.21

Comorbidity

No

105

90

3.86(1.71–8.72)

1

.

Yes

36

8

2.79(0.88–8.82)

0.08

Recent admission

No

105

91

1.90(0.76–4.75)

1

.

Yes

18

7

1.79(0.59–5.37)

0.30

Phenytoin

No

43

39

1.51(0.88–2.59)

1

.

Yes

98

59

1.42(0.67-3.00)

0.36

Valproic acid

No

119

74

0.57(0.30–1.09)

1

.

Yes

22

24

0.58(0.23–1.43)

0.23

Gum hypertrophy

No

135

89

0.44(0.15–1.28)

1

.

Yes

13

20

0.32(0.12–0.81)

0.02

Depression

No

128

78

0.40(0.19–0.84)

1

.

Yes

6

9

0.55(0.15–2.06)

0.38